
Uppsala Reports editor
@UMCGlobalSafety
Communications / 06 November 2023
To celebrate #MedSafetyWeek, Drug Safety Matters presents a two-part episode on medicine safety communication campaigns and how they help us spread the pharmacovigilance message.
This year, #MedSafetyWeek takes place from 6–12 November, with the theme “Who can report?” In the first of a special two-part episode on pharmacovigilance communication campaigns, Federica Santoro of the Drug Safety Matters podcast speaks to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.
Their discussion covers the long-standing problem of under-reporting in pharmacovigilance systems, how regulators can encourage the public to report side-effects, and why reports from both patients and healthcare professionals are necessary for effective pharmacovigilance.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
Ronald Meyboom, pioneering pharmacovigilance expert who helped establish drug safety monitoring in the Netherlands, died 27 April. He was 79.
11 June 2025
Prof. Singhal passed away on 19 April 2025. He is survived by his wife, children, and a large community of pharmacology researchers who had the privilege of training under him.
02 July 2025
Public health is at risk now more than ever; with AI it has never been easier to spread mis- and disinformation on health. How do we work smarter to address this threat?
17 June 2025